title: [Chapter 4. Transitions in pharmaceutical market, production and sales in Japan (1980-2010)].
abstract: In this paper, the writers reviewed in detail the pharmaceutical market and the shifts in manufacturing and sales including the trade balance in Japan over a thirty-year period from 1980 to 2010. From the 1980s to the 1990s, many innovative pharmaceutical products were developed and launched in the Japanese market. During the same period, some Japanese companies managed to develop their first internationally marketable drugs, which were antibiotics and effective remedies for the digestive and circulatory organs. During this period, Japanese pharmaceutical companies were also able to launch some of blockbuster drugs. For two decades, the pharmaceutical market grew rapidly. For this reason, it can be called "The Growth Period for Pharmaceutical Products" in Japan. After that period, drug development and sales slowed down due to a lack of expertise in genetic engineering and biotechnologies. This situation caused a large deficit in the trade balance for Japanese pharmaceutical products. However, with regard to the trade balance (including technical royalties) for pharmaceutical product technologies, Japan remains in the black even today.
authors.forename: Ryuzo
authors.initials: R
authors.lastname: Yoshioka
authors.forename: Kazuo
authors.initials: K
authors.lastname: Matsumoto
mesh_terms: D003132:Commerce; D004345:Drug Industry / Q000266:history*; D049673:History, 20th Century; D049674:History, 21st Century; D007564:Japan